Skip to main content

pharmaceutic

Ampules, syringe, tablets and spray

Could a ‘European Medicines Infrastructure’ help solve market failures in pharmaceutical research and development?

Interview with Massimo Florio (Professor of Public Economics, University of Milan, Italy) about a new European approach to pharmaceutical policy. In response to the Covid-19 crisis, the European Union has increased its commitment to the EU public health agenda. It has strengthened the mandate of both the European Medicines Agency (EMA) and the European Centre ...

EU Project PATH TOX ESMH

EU Project : PATH-TOX

PATH-TOX: Drug discovery is a time consuming, expensive and risky process. Each drug to market must undergo safety/ toxicity testing in animals which yields thousands of tissue sections that currently must be assessed manually by a trained veterinary pathology. However, there is a looming crisis due to the lack pathologists. The PATH-TOX consortium is led ...

Antibiotics on farms: Europe starts to curb bad practices

Antibiotics on farms: Europe starts to curb bad practices

Resistant infections kill an estimated 33 000 people in the European Union annually.